Congressman Sam Liccardo is honest, direct, and refreshingly optimistic. Formerly the mayor of San Jose, he was elected to represent California’s 16th congressional district nearly two years ago. He recently visited Fogarty Innovation to host “From Silicon Valley to...
“We all share the goal of helping patients and their doctors have access to better devices to improve healthcare,” said Sonja Fulmer, PhD, deputy director for the Digital Health Center of Excellence (DHCoE) in the FDA Center for Devices and Radiologic Health (CDRH)....
Fogarty Innovation’s Lunch & Learn sessions provide a unique opportunity for knowledge sharing amongentrepreneurs and members of the industry as a key part of the organization’s mission to empower innovators in their quest to transform healthcare and...
Recognized as one of the top lobbyists and negotiators for the medtech sector, Mark Leahey, president and CEO of MDMA and Fogarty Innovation's board member, continues to make an unparalleled impact on our industry. Over the course of his career, he has...
Fogarty Innovation’s policy partner, Medical Device Manufacturers Association (MDMA), recently held its annual Medical Technology Executive Forum, featuring the industry’s leading CEOs and senior executives to discuss the critical issues and insights affecting the...
Every year medtech professionals look forward to the FDA Forum hosted by Medical Device Manufacturers Association (MDMA), Fogarty Innovation’s policy partner. This year, the two-day virtual event once again gave valuable insight to attendees on key...
Do you speak fluent CPT®? If not, as a health technology entrepreneur, you likely need to learn more about how a new medical device or procedure fits into the Current Procedural Terminology (CPT) code landscape. That was the topic of a recent American Medical...
The Medical Device Manufacturers Association (MDMA) has been a beacon during the COVID-19 crisis, working closely with the FDA and other key stakeholders to represent the needs of its members and bring innovative devices to patients swiftly but safely. That’s why...
Since there’s nothing more fascinating than a peek behind the curtain, Stanford Biodesign’s most recent “From the Innovator's Workbench” event featuring former FDA commissioner from 2017 to 2019, Scott Gottlieb, MD, was a big draw. More than 400 people attended the...
The show must go on, especially when it is something as important to the industry as the MDMA’s Medical Technology Executive Forum, now in its 13th year. Hosted by MDMA president and CEO Mark Leahey, the virtual event was extremely successful, highlighting how nimble...